Jessica Foley, PhD, PsyD

Title(s)Beh Program Crd, Neurology
SchoolChancellor/EVC/FAS
Address1500 Owens St.
San Francisco CA 94158
Phone--
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Biography 
    Collapse Education and Training
    UCLA School of MedicineNeuropsychology Postdoctoral Fellowship2009Semel Institute for Neuroscience and Human Behavior
    Brown Medical SchoolInternship, Neuropsychology Specialization2007Department of Psychiatry and Biobehavioral Sciences
    Nova Southeastern UniversityPhD2007Center for Psychological Studies
    Nova Southeastern UniversityPsyD2007Center for Psychological Studies
    Harvard UniversityBachelor of Liberal Arts2002
    Collapse Awards and Honors
    American Board of Clinical Neuropsychology2014Diplomat in Clinical Neuropsychology
    Harvard Medical School2014  - 2014Academy Member, Academy Center for Teaching and Learning
    Florida Psychological Association2005  - 2005First Place Research Award
    Broward County Psychological Association2004  - 20057th Annual Young Clinician Award
    American Psychological Association, Society for Clinical Psychology2004  - 2005Distinguished Student Award
    Nova Southeastern University Center for Psychological Studies2003  - 2004First Place Research Award
    Harvard University2001  - 2002Dean's List Academic Achievement Award

    Collapse Overview 
    Collapse Overview
    Jessica M Foley, Ph.D., ABPP-CN
    Board Certified Clinical Neuropsychologist
    Assistant Clinical Professor, Department of Neurology

    Dr. Jessica Foley is a board certified Clinical Neuropsychologist and Assistant Clinical Professor of Neurology, who has served within the Memory and Aging Center of the UCSF School of Medicine since 2014. Dr. Foley was awarded a Bachelor’s degree from Harvard University in 2002, followed by a Ph.D. and Psy.D. from Nova Southeastern University (2007) with a specialization in clinical neuropsychology. She completed predoctoral internship training specializing in neuropsychology at Brown Medical School Department of Psychiatry, and postdoctoral fellowship training in neuropsychology at the UCLA Semel Institute for Neurosciences and Human Behavior. She previously (2009-2014) served as a Neuropsychologist and Instructor of Psychiatry within the Harvard Medical School Department of Psychiatry and the Boston VA Medical Center, where she functioned as the senior Neuropsychologist within the Brockton division (specialized in the assessment of medically complex older adults). She also served as faculty within the Boston Consortium in Clinical Psychology and Training Leader for neuropsychology training within the geropsychology internship and fellowship programs.

    Dr. Foley currently functions as an Attending Neuropsychologist within the UCSF Department of Neurology Memory and Aging Center, in which capacity she serves a multidisciplinary team and performs neuropsychological evaluations for patients presenting with suspicion of neurodegenerative illness. She also performs comprehensive neuropsychological evaluations of adults with a variety of known or suspected neurologic illnesses through the Department of Neurology Adult Outpatient Neuropsychology Clinic. Dr. Foley also serves as a faculty mentor for neuropsychology students in training, supporting clinical and research skills among developing scientist-practitioners in clinical neuropsychology.

    Dr. Foley’s primary research interest concerns preclinical detection of Alzheimer’s disease and other neurodegenerative conditions by exploring genetic, metabolic, and cognitive factors that predict brain white matter deterioration. An additional interest entails understanding factors that moderate cognitive and white matter changes in older adults with HIV-infection.



    Funded Grants:

    1. Preferential white matter degeneration among individuals at genetic risk for Alzheimer's disease vs. Healthy Older Controls: A Diffusion Tensor Imaging study
    Role: Principal Investigator
    Funding Source: American Psychological Association Division 40 (Neuropsychology)
    Funding Period: February, 2011-August, 2014

    2. Effects of Aging on White Matter Pathology in HIV versus other Neurodegenerative Illnesses
    Role: Principal Investigator
    Funding Source: National Institutes of Health (NIH) National Institutes of Aging (NIA) Clinical Research Loan Repayment Program (LRP; declined due to conflict)
    Funding Period: August, 2009- August, 2011

    3. White matter pathology, cognition and functional abilities in geriatric HIV
    Role: Principal Investigator
    Funding Source: UCLA AIDS Institute and the UCLA Center for AIDS Research (AI28697)
    Funding Period: June, 2008-June, 2009

    4. The influence of Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) on Cognition:
    Functional Magnetic Resonance Imaging (fMRI) study (PI: Susan Bookheimer, Ph.D.)
    Role: Co-Investigator (replacement)
    Funding Source: UCLA Faculty Senate Grant (FAU 56199 AQ 19914)
    Funding Period: January, 2007-June, 2009


    Ad Hoc Review
    Journals: The Clinical Neuropsychologist, AIDS and Behavior, Journal of Clinical and Experimental Neuropsychology, Archives of Clinical Neuropsychology, Child Neuropsychology, European Journal of Neurology, American Journal of Alzheimer’s Disease and Other Dementias
    Abstracts: National Academy of Neuropsychology, HIV Prevention Conference

    Grant Review
    Reviewer Alzheimer’s Association International Research Grants Program (2014-current)
    Reviewer APA Division 40 (Neuropsychology) Pilot Grants (2012-2014)
    Reviewer Benton Meier Neuropsychology Scholarship ( 2012-2014)
    Reviewer APA Division 40 (Neuropsychology) Blue Ribbon Award (2012-2014)
    Reviewer Society for Clinical Neuropsychology Early Career Award (2012-2014)

    Board Certification Work Sample Review
    Reviewer American Board of Clinical Neuropsychology (ABCN) (2015-current)

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Depressive Symptom Profiles Predict Specific Neurodegenerative Disease Syndromes in Early Stages. Front Neurol. 2020; 11:446. Shdo SM, Ranasinghe KG, Sturm VE, Possin KL, Bettcher BM, Stephens ML, Foley JM, You SC, Rosen HJ, Miller BL, Kramer JH, Rankin KP. PMID: 32547476.
      View in: PubMed   Mentions:
    2. Long-term test-retest reliability of the California Verbal Learning Test - second edition. Clin Neuropsychol. 2017 Nov; 31(8):1449-1458. Alioto AG, Kramer JH, Borish S, Neuhaus J, Saloner R, Wynn M, Foley JM. PMID: 28387582.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    3. White matter hyperintensities correlate to cognition and fiber tract integrity in older adults with HIV. J Neurovirol. 2017 06; 23(3):422-429. Watson C, Busovaca E, Foley JM, Allen IE, Schwarz CG, Jahanshad N, Nir TM, Esmaeili-Firidouni P, Milanini B, Rosen H, Carmichael OT, Thompson PM, Valcour VG. PMID: 28101804.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    4. Mild Cognitive Impairment is Associated With White Matter Integrity Changes in Late-Myelinating Regions Within the Corpus Callosum. Am J Alzheimers Dis Other Demen. 2016 Feb; 31(1):68-75. Stricker NH, Salat DH, Kuhn TP, Foley JM, Price JS, Westlye LT, Esterman MS, McGlinchey RE, Milberg WP, Leritz EC, Stricker NH, Salat DH, Kuhn TP, Foley JM, Price JS, Westlye LT, Esterman MS, McGlinchey RE, Milberg WP, Leritz EC. PMID: 25904759; PMCID: PMC4913466.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    5. Glucose dysregulation interacts APOE-4 to potentiate temporoparietal cortical thinning. American Journal of Alzheimer’s Disease and Other Dementias. 2015; epub ahead of print. .
    6. Increased frontal-subcortical neural activity among HIV+ individuals during a lexical retrieval task. Neurobiology of Disease. 2015; in press. .
    7. Neurocognitive Disorders in Aging: A Primer on DSM-5 Changes and Framework for Application to Practice. The Clinical Gerontologist. 2014; 37:317-346. .
    8. GeroCentral [Internet]. Decision Making Capacity Clinical Toolbox. Introduction: Decision Making Capacity. 2014. . View Publication.
    9. The SAGE Encyclopedia of Abnormal and Clinical Psychology. California Verbal Learning Test. 2014; In press. .
    10. Interactive effects of apolipoprotein E4 and diabetes risk on later myelinating white matter regions in neurologically healthy older aged adults. Am J Alzheimers Dis Other Demen. 2014 May; 29(3):222-35. Foley JM, Salat DH, Stricker NH, Zink TA, Grande LJ, McGlinchey RE, Milberg WP, Leritz EC, Foley JM, Salat DH, Stricker NH, Zink TA, Grande LJ, McGlinchey RE, Milberg WP, Leritz EC. PMID: 24381137; PMCID: PMC4356251.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    11. Decision making among HIV+ adults: the influence of neurocognition, sensation seeking and personality. Journal of the International Neuropsychological Society. 2013; 27(4):279, abstract. .
    12. Implicit Learning among patients with HIV/AIDS: The Role of Cognitive Reserve. Journal of the International Neuropsychological Society. 2013; 27(4):278, abstract. .
    13. Probabilistic Learning and Basal Ganglia Integrity among HIV+ Older Adults: A Diffusion Tensor Imaging Study. Journal of the International Neuropsychological Society. 2013; 27(4):279, abstract. .
    14. Visuospatial and attentional abilities predict driving simulator performance among older HIV-infected adults. American Journal of Alzheimer’s disease and Other Dementias. 2013; 28(2):185-194. .
    15. Decreased White Matter Integrity in Neuropsychologically-Defined Mild Cognitive Impairment is Independent of Cortical Thinning. Journal of the International Neuropsychological Society. 2013; 19:1-13. .
    16. Cognitive reserve in older neurocognitively unimpaired HIV-infected patients at risk for decline. Applied Neuropsychology. 2012; 19:16-25. .
    17. Basal ganglia differentially contribute to verbal fluency among HIV-infected adults. Neuropsychologia. 2012; 50(3):390-395. .
    18. Comparison of Verbal Fluency Switching Measures in HIV. Journal of the International Neuropsychological Society. 2011; 17:87, Abstract. .
    19. Cognitive reserve masks the neurobehavioral expression of Human Immunodeficiency Virus (HIV)-associated neurological disorder among older patients. Neurobehavioral HIV Medicine. 2011; 3:87-93. .
    20. Depression, cognition, and self-appraisal of functional abilities in HIV: an examination of subjective appraisal versus objective performance. The Clinical Neuropsychologist. 2011; 25:224-243. .
    21. The Encyclopedia of Neuropsychological Disorders. Wallenberg Syndrome. 2011; 751-52. .
    22. The Encyclopedia of Neuropsychological Disorders. Zellweger Syndrome. 2011; 775-776. .
    23. Neuroimaging of lexico-semantic retrieval impairments among older HIV-infected adults: An FMRI study. Journal of the International Neuropsychological Society. 2011; 17:109, Abstract. .
    24. Gray matter integrity among older adults with HIV: the effects of age and immunological compromise. The Clinical Neuropsychologist. 2011; 25:4, Abstract. .
    25. Medication and Finance Management among HIV-infected adults: The impact of age and cognition. Journal of Clinical and Experimental Neuropsychology. 2011; 33:200-209. .
    26. Review of the book Neuropsychology and cardiovascular disease]. Journal of Clinical and Experimental Neuropsychology. A comprehensive update on the neuropsychology of cardiovascular disease. 2011; 3:1-3. .
    27. Past stimulant abuse is associated with basal ganglia and hippocampal integrity in older HIV+ adults: A Diffusion Tensor Imaging study. Journal of AIDS and Clinical Research. 2011; 2(6):128-133. .
    28. Antiretroviral adherence and the nature of HIV-associated verbal memory impairment. Journal of Neuropsychiatry and Clinical Neuropsychiatry and Clinical Neurosciences. 2011; 23(3):324-331. .
    29. Neurocognitive functioning in HIV-1-infection: effects of cerebrovascular risk factors and age. The Clinical Neuropsychologist. 2010; 24:265-285. .
    30. Operationalization of the updated diagnostic algorithm for classifying HIV-related cognitive impairment and dementia. International Psychogeriatrics,. 2010; 19:1-9. .
    31. Reaction Time Variability in HIV+ Individuals. Journal of the International Neuropsychological Society. 2010; 25:791-798. .
    32. Intraindividual Variability, Age, and Driving Ability in HIV+ Adults. Journal of the International Neuropsychological Society. 2010; 16:22, abstract. .
    33. HAART adherence and the expression of verbal memory impairment in HIV. Journal of Neuropsychiatry and Clinical Neurosciences. 2010; 22:49, Abstract. .
    34. Longitudinal study of neurocognition in aging HIV+ adults. Journal of the International Neuropsychological Society. 2010; 16:26, Abstract. .
    35. Reciprocal Prediction of Medication Adherence and Neurocognition in HIV/AIDS. Neurology. 2010; 74:1217-1222. .
    36. Neurocognitive Deficits Among HIV + Hypertensive Adults. Journal of the International Neuropsychological Society. 2010; 16:27, Abstract. .
    37. Longitudinal Changes in Medication Adherence among HIV+ Adults: Relationship with Neurocognition and Changes in Psychiatric Functioning. Archives of Clinical Neuropsychology. 2009; 16:25, Abstract. .
    38. Aging, Neurocognition, and Medication Adherence in HIV Infection: A Latent Modeling Approach. American Journal of Geriatric Psychiatry. 2009; 17:281-29. .
    39. IQ predicts neuropsychological performance in children. International Journal of Neuroscience. 2009; 119(10):1830-1847. .
    40. Effects of cerebrovascular risk versus age upon cognitive functioning in HIV-1-infected patients. Journal of the International Neuropsychological Society. 2009; 15:99, abstract. .
    41. Functional consequences of HIV-1 infection. Neuropsychology Review. 2009; 19:186-204. .
    42. Pattern of memory performance in HIV/AIDS when compared to psychiatric, neuropsychiatric, and normal control groups. International Journal of Neuroscience. 2009; 119(10):1779-1803. .
    43. Corollary and discrepancy-based approaches for examining the appropriateness of premorbid cognitive estimation in geriatric schizophrenia. International Journal of Neuroscience. 2009; 119(10):1810-1829. .
    44. Changes in cerebral volumes among healthy older adults with and without the Apolipoprotein Epsilon 4 genetic risk for Alzheimer’s disease: a longitudinal study. Journal of the International Neuropsychological Society. 2009; 15:54, abstract. .
    45. White matter integrity, age, and executive functioning: a diffusion tensor imaging study. The Clinical Neuropsychologist. 2009; 23:616, abstract. .
    46. Archives of Clinical Neuropsychology. Microstructural brain pathology and its effect upon cognition and functional abilities in older HIV. 2009; Abstract. .
    47. Pattern of memory compromise in chronic geriatric schizophrenia, frontotemporal dementia, and normal geriatric controls. Acta Neuropsychiatrica. 2008; 20(1):9-19. .
    48. Current HIV/AIDS Reports. Emerging Issues in the Neuropsychology of HIV-Infection. 2008; 5(4):204-211. .
    49. Classification of HIV-related cognitive decline and dementia differs by functional assessment method. Journal of the International Neuropsychological Society. 2008; 14:145, abstract. .
    50. Cognitive Impairment, Hippocampal Volume, and White Matter Integrity in CADASIL. Journal of the International Neuropsychological Society. 2007; 13:95, Abstract. .
    51. Examination of Premorbid Intellectual Estimation in Geriatric Schizophrenia and Frontotemporal Dementia. Journal of the International Neuropsychological Society. 2007; 13:82, abstract. .
    52. Processing speed in CADASIL: Relationship to cingulum versus callosal fibers. Poster presented at the 3rd annual conference of the International Society for Vascular Behavioral and Cognitive Disorders. 2007; San Antonio, Tx. .
    53. Nature and pattern of memory decline in Schizophrenia versus Frontotemporal Dementia. Journal of the International Neuropsychological Society. 2007; 13:89, abstract. .
    54. Can the MMPI-2 discriminate between mild-moderate TBI and other neurologic and psychiatric populations?. International Journal of Neuroscience. 2006; 116(12):1-13. .
    55. Nature and extent of neuropsychological compromise in older seriously mentally ill populations. Journal of the International Neuropsychological Society. 2006; 19:240, abstract. .
    56. Using community outreach to promote integrative health care: A pilot study. Professional Psychology: Research and Practice. 2006; 37(2):125-131. .
    57. Gender discrepancies in processing speed across the lifespan. Journal of the International Neuropsychological Society. 2006; 19:193, abstract. .
    58. Effects of age and education on cognitive processes and executive function performance in older women. Archives of Clinical Neuropsychology. 2006; 21:564, Abstract. .
    59. Evidence for a subcortical pattern of neuropsychological deficits in HIV/AIDS patients. Journal of the International Neuropsychological Society. 2006; 19:175, Abstract. .
    60. Neuropsychological impairment as a confound in the interpretation of the Minnesota Multiphasic Personality Inventory, Second Edition, Infrequency Scale. Journal of the International Neuropsychological Society. 2005; 11:86-87, abstract. .
    61. PsycCRITIQUES--Contemporary Psychology: APA Review of Books. (2005). Reinterpretation of the MMPI-2: A new direction? [Review of the book The Clinical Interpretation of the MMPI-2: A Content Cluster Approach. 2005; 50(23). .
    62. The Sensitivity and specificity of the WCST to detect executive dysfunction in adults. Journal of the International Neuropsychological Society. 2005; 11:100, abstract. .
    63. Gender differences in verbal and visual memory on the WMS-III in an adult neuropsychiatric population. Archives of Clinical Neuropsychology. 2005; 20:915, abstract. .
    64. Effects of Parkinson’s Disease on verbally mediated frontal lobe tasks. The Clinical Neuropsychologist. 2005; 19:Abstract. .
    65. Cognitive decline in normal older adults and adults with serious mental illness. Archives of Clinical Neuropsychology. 2004; 19:952, abstract. .
    66. Empirically supported treatment endeavour: Successful future or an inevitable debacle?. Clinical Psychologist. 2004; 8:29-38. .
    67. Clinical relationship of coping deficits to frontal lobe damage. Archives of Clinical Neuropsychology. 2004; 19:902, abstract. .
    68. Independent Practitioner. Review of the Book Addressing Cultural Complexities in Clinical Practice: A Framework for Clinicians and Counselors. 2003; 23:112-114. .
    Jessica's Networks
    Concepts (33)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (15)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.1.0-868-g8ba5679c on PROFILES-PWEB02.

    Copyright © The Regents of the University of California